Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

Omada Health, a virtual chronic care provider, filed to go public Friday, marking the second digital health company making ...

After nearly 18 years on medication to manage her high blood pressure, Charity Wischmeyer, 51, is now discussing with her ...

Simultaneous liver transplant and sleeve gastrectomy (LTSG) yield durable weight loss, resolution of diabetes and ...

The National Center for Complementary and Integrative Health states that "research doesn't clearly support using cinnamon for ...

GLP-1 receptor agonists remain blockbuster drugs for weight management for people with overweight or obesity. Increasingly, ...

Nutritional counseling remains a central component of obesity treatment, even in the era of highly effective weight-loss ...

Gov. Glenn Youngkin saved about $7 million in state funds and $40 million in federal funds by vetoing a lower body-mass index ...

The drug enhances outcomes in a high-risk patient population with a significant unmet need. Tirzepatide significantly ...

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide, or GIP, and glucagon-like peptide-1, or GLP-1, receptor agonist, has shown promise in promoting weight loss and improving ...